Thomas Marjot

, United Kingdom


Presentations

SGLT2 inhibition does not reduce hepatic steatosis in overweight, insulin resistant patients without type 2 diabetes 12 April 2019 16:30 - 16:45
The effect of metformin on hepatic fatty acid partitioning; an investigation using human in vivo and in vitro models 13 April 2019 09:00 - 17:00
The effect of metformin on hepatic fatty acid partitioning; an investigation using human in vivo and in vitro models 12 April 2019 12:30 - 13:30

Abstracts

SGLT2 inhibition does not reduce hepatic steatosis in overweight, insulin resistant patients without type 2 diabetes NAFLD: Therapy More